Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avrobio Inc (AVRO)
NASDAQ:AVRO
Avrobio (AVRO) Stock Price & Analysis
314 Followers
AVRO Stock Chart & Stats
Day’s Range$16.56 - $17.28
52-Week Range― - ―
Previous Close$17.04
Volume206.82K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
May 09, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Avrobio News
PremiumCompany Announcements
Avrobio Merges with Tectonic, Emerges as Tectonic Therapeutic
PremiumCompany Announcements
Avrobio and Tectonic Discuss Merger in Webcast Event
PremiumCompany Announcements
Avrobio and Tectonic Announce Merger Agreement ExecutionRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AVRO FAQ
What was Avrobio Inc’s price range in the past 12 months?
Currently, no data Available
What is Avrobio Inc’s market cap?
Currently, no data Available
When is Avrobio Inc’s upcoming earnings report date?
Avrobio Inc’s upcoming earnings report date is May 09, 2024 which is 58 days ago.
How were Avrobio Inc’s earnings last quarter?
Avrobio Inc released its earnings results on Mar 20, 2024. The company reported -$0.35 earnings per share for the quarter, the consensus estimate of -$0.35 by $0.
Is Avrobio Inc overvalued?
According to Wall Street analysts Avrobio Inc’s price is currently Overvalued.
Does Avrobio Inc pay dividends?
Avrobio Inc does not currently pay dividends.
What is Avrobio Inc’s EPS estimate?
Avrobio Inc’s EPS estimate is -$0.36.
How many shares outstanding does Avrobio Inc have?
Currently, no data Available
What happened to Avrobio Inc’s price movement after its last earnings report?
Avrobio Inc reported an EPS of -$0.35 in its last earnings report, expectations of -$0.35. Following the earnings report the stock price went down -0.794%.
Which hedge fund is a major shareholder of Avrobio Inc?
Among the largest hedge funds holding Avrobio Inc’s share is Aisling Capital Management LP. It holds Avrobio Inc’s shares valued at 16M.
---
Avrobio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AVRO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 312.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $970.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.15%
12-Months-Change
Fundamentals
Return on Equity
42.73%
Trailing 12-Months
Asset Growth
11.26%
Trailing 12-Months
Company Description
Avrobio Inc
Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on gene therapy for fabry, gaucher, pompe disease, and cystinosis. These gene therapies, on which the company was founded, were developed by Dr. Jeffrey Medin and Dr. Christopher Paige at the University Health Network. AvroBio launched in 2015, is headed by Co-Founder, President and CEO Geoff Mackay, and is headquartered in Cambridge, MA.
---
AVRO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Adverum Biotechnologies
―
Meiragtx Holdings
―
Kiniksa Pharmaceuticals
―
Sangamo Biosciences
―
Best Analysts Covering AVRO
1 Year
---